Such shifts are significant in posterior distributions of mutations, such as the S33P mutation in the CTNNB1 gene in the LIHC tumor type and the Q61R mutation in the HRAS gene in the THCA tumor type (Fig 4A). This evidence concerns the gene CTNNB1 and neoplasm.